Listeria Antibody, CSF
CBFB-MYH11 inv(16) Gene Fusion, Quantitative
Calcium Sensing Receptor (CASR) Gene Mutation Analysis
Sickle Cell Anemia Genetic Analysis
Bartonella Antibody, IgM, Serum
c-KIT Mutation Analysis, Blood, Bone Marrow
Protein Immunofixation Electrophoresis, Urine
Leukocyte Alkaline Phosphatase
Myelin Oligodendrocyte Glycoprotein (MOG), Antibody, Serum
Polycystic Kidney Disease, Autosomal Recessive (PKHD1), Gene Analysis
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Clinical Utility
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now